| P2093 | author name string | Jing Zhang | |
| | Daxin Wang | |
| | Shenghu He | |
| P2860 | cites work | Homocysteine, iron and cardiovascular disease: a hypothesis | Q27691810 |
| | Inflammation, atherosclerosis, and coronary artery disease | Q29547232 |
| | Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 |
| | Atherosclerosis. the road ahead | Q29618972 |
| | Progress and challenges in translating the biology of atherosclerosis | Q29619982 |
| | Pharmacokinetics and biodistribution of a human monoclonal antibody to oxidized LDL in cynomolgus monkey using PET imaging | Q34428136 |
| | Relationship between oxidized low-density lipoprotein antibodies and obesity in different glycemic situations | Q34434803 |
| | Proatherogenic oxidized low-density lipoprotein/β2-glycoprotein I complexes in arterial and venous disease | Q34487399 |
| | Assay methods of modified lipoproteins in plasma | Q35008817 |
| | Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies | Q35014306 |
| | Consolidated and emerging inflammatory markers in coronary artery disease | Q35019922 |
| | Vascular biology of atherosclerosis: overview and state of the art. | Q35088517 |
| | Reduced IgM levels and elevated IgG levels against oxidized low-density lipoproteins in HIV-1 infection | Q35122438 |
| | Is atherosclerosis an autoimmune disease? | Q35123740 |
| | Lipoprotein autoantibodies: measurement and significance | Q35140009 |
| | Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit. | Q35817369 |
| | Oxidized low-density lipoprotein | Q35860737 |
| | Systemic lupus erythematosus, atherosclerosis, and autoantibodies | Q36242825 |
| | Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease | Q36789663 |
| | Autoimmunity in atherosclerosis: a protective response losing control? | Q37138017 |
| | Development and application of a nonradioactive binding assay of oxidized low-density lipoprotein to macrophage scavenger receptors | Q37222736 |
| | Investigation of serum oxidized low-density lipoprotein IgG levels in patients with angiographically defined coronary artery disease | Q37594647 |
| | Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment | Q37699846 |
| | Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment | Q37833721 |
| | Role of macrophage scavenger receptors in atherosclerosis | Q37995838 |
| | Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases | Q38299279 |
| | Multi-radionuclide digital autoradiography of the intra-aortic atherosclerotic plaques using a monoclonal antibody targeting oxidized low-density lipoprotein | Q38834917 |
| | Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population | Q40402572 |
| | Oxidized LDL and atherogenesis: relation to risk factors for coronary heart disease. | Q40896289 |
| | Oxidized Low-Density Lipoprotein and Atherosclerosis | Q43816762 |
| | Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males | Q44120865 |
| | Association of high coronary heart disease risk status with circulating oxidized LDL in the well-functioning elderly: findings from the Health, Aging, and Body Composition study | Q44468908 |
| | Increased microvascular permeability in the hamster cheek pouch induced by oxidized low density lipoprotein (oxLDL) and some fragmented apolipoprotein B proteins. | Q44482438 |
| | Autoantibodies against oxidized LDLs and atherosclerosis in type 2 diabetes | Q45285728 |
| | Autoantibodies to oxidized low-density lipoprotein in patients with aortic regurgitation: association with aortic diameter size | Q47182599 |
| | Neither oxidized nor anti-oxidized low-density lipoprotein level is associated with atherosclerosis or mortality in hemodialysis patients. | Q47911686 |
| | Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes. | Q51008381 |
| | Pneumococcal vaccination may induce anti-oxidized low-density lipoprotein antibodies that have potentially protective effects against cardiovascular disease | Q64457671 |
| | Homocystinuria, arteriosclerosis, methylmalonic aciduria, and methyltransferase deficiency: a key case revisited | Q68114666 |
| | Hyperhomocysteinemia: an independent risk factor for vascular disease | Q70131136 |
| | Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population | Q73536901 |
| | Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease | Q78502800 |
| | Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective? | Q80908056 |
| | Oxidized low-density lipoprotein/beta2-glycoprotein I complexes and autoantibodies in patients with type 2 diabetes mellitus | Q81125933 |
| | Adaptive immunity is related to coronary artery disease severity after acute coronary syndrome in subjects with metabolic syndrome | Q83977085 |
| | oxLDL/beta2GPI complex and anti-oxLDL/beta2GPI in SLE: prevalence and correlates | Q84660809 |
| | Anti-ox-LDL antibodies and anti-ox-LDL-B2GPI antibodies in patients with systemic lupus erythematosus | Q85618243 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| | lipoprotein | Q28350 |
| P304 | page(s) | 11922-9 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | International Journal of Clinical and Experimental Medicine | Q6051338 |
| P1476 | title | Roles of antibody against oxygenized low density lipoprotein in atherosclerosis: recent advances | |
| P478 | volume | 8 | |